glp 1 agonists with cardiovascular benefit Bridging the gap between GLP1-receptor and outcomes: evidence for the role of tirzepatide | Cardiovascular Diabetology glp 1 inhibitors mechanism of
Description
Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases
doi: 10.1001/jama.2015.9676 10 DaviesM
[16] These receptors, when activated by allulose, may trigger signalling cascades that promote incretin hormone release, though the magnitude and clinical significance of this effect in humans requires further investigation
Sci Rep 9 , 8447 (2019)
Statistical Analysis The researchers used a meta-analysis method to study how GLP-1 activity affects various inflammatory markers
